Analysis of the Electrical Muscle Activity and Resistance to Movement in Spastic Hemiparetic Patients. (EENM)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01945151|
Recruitment Status : Unknown
Verified September 2013 by Universidade do Vale do Paraíba.
Recruitment status was: Recruiting
First Posted : September 18, 2013
Last Update Posted : September 18, 2013
To evaluate and compare the effects of Neuromuscular Electrical Stimulation when applied in the agonist and antagonist muscles of spastic hemiparetic patients.
The specific objectives are:
- Evaluate the resistance movement, strength and muscle electrical activity before and after application of Neuromuscular Electrical Stimulation in spastic muscle (gastrocnemius).
- Evaluate the resistance movement, strength and muscle electrical activity before and after application of Neuromuscular Electrical Stimulation in the spastic antagonist muscle (tibialis anterior).
- Compare the risk of falls after application of Neuromuscular Electrical Stimulation in both muscles studied.
|Condition or disease||Intervention/treatment||Phase|
|Cerebrovascular Accident||Other: Group 2 (G2) NMES is applied in the spastic muscle (gastrocnemius).||Not Applicable|
Most hemiparetic patients can develop spasticity, characterized by neuronal hyperexcitability, increased resistance to passive stretch, Babinski sign, clonus, reflexes and involuntary spasms skin.
As a consequence, there may be contractures and muscle shortening, generating functional limitations. Neuromuscular Electrical Stimulation feature that can control the spasticity through reciprocal inhibition, muscle relaxation and sensory stimulation. The goal will be to evaluate and compare the effects of neuromuscular electrical stimulation when applied in the agonist and antagonist muscles of spastic hemiparetic patients.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||15 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Analysis of the Electrical Muscle Activity and Resistance to Movement After Pplication Neuromuscular Electrical Stimulation (EENM) in Patients With Hemiparesis Spastic.|
|Study Start Date :||June 2013|
|Estimated Primary Completion Date :||September 2013|
|Estimated Study Completion Date :||November 2013|
Experimental: Group 1 (G1) NMES is applied in the spastic antagonist muscle
The parameters considered for the application of NMES are: frequency of 50Hz, the wavelength of 350m / s, 10 seconds of contraction of 20 seconds of rest to total 15 minutes. During the application of NMES patients will be positioned supine on the bed with knees flexed semi supported on roller positioning. The G1 apply NMES on the motor point of the tibialis anterior and triceps surae lengthening held along with the contraction (reciprocal inhibition).
Other: Group 2 (G2) NMES is applied in the spastic muscle (gastrocnemius).
The G2 apply NMES in the gastrocnemius motor point and the rest will be done during stretching of the gastrocnemius muscle (autogenic inhibition). Five consecutive sessions will be held in the morning and afternoon in the laboratory of Sensory Motor Rehabilitation Engineering.
- Analysis of the electrical muscle activity and resistance to movement after application of neuromuscular electrical stimulation (NMES) in patients with spastic hemiparesis. [ Time Frame: 12 months ]The G1 apply Neuromuscular Electrical Stimulation on the motor point of the tibialis anterior and triceps surae lengthening held along with the contraction (reciprocal inhibition). The G2 apply electrical muscle activity and resistance to movement after application of neuromuscular electrical stimulation (NMES) in patients with spastic hemiparesis.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01945151
|Contact: Sergio ST Takeshi, pesquisadora||55 12 39947 1000 ext firstname.lastname@example.org|
|Laboratório de Engenharia de Reabilitação Sensorio Motora||Recruiting|
|São José dos Campos, São Paulo, Brazil, 55|
|Contact: Sergio ST Takeshi, pesquisadora 55 12 8137-1012 ext 2066 email@example.com|
|Principal Investigator:||Sergio ST Takeshi, pesquisador||Universidade do Vale do Paraíba|